BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barrett FS, Zhou Y, Carbonaro TM, Roberts JM, Smith GS, Griffiths RR, Wong DF. Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation. Front Neuroergonomics 2022;2:784576. [DOI: 10.3389/fnrgo.2021.784576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Meccia J, Lopez J, Bagot RC. Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms. Psychopharmacology (Berl) 2023;240:27-40. [PMID: 36564671 DOI: 10.1007/s00213-022-06297-0] [Reference Citation Analysis]
2 Casey AB, Cui M, Booth RG, Canal CE. "Selective" serotonin 5-HT2A receptor antagonists. Biochem Pharmacol 2022;:115028. [PMID: 35381208 DOI: 10.1016/j.bcp.2022.115028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]